Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Most patients with disorders of gut‐brain interaction receive pharmacotherapy with major or moderate drug‐gene interactions

Neurogastroenterology & Motility(2023)10.1111/nmo.14722Source: DataRank Database

Most patients with disorders of gut‐brain interaction receive pharmacotherapy with major or moderate drug‐gene interactions is a research paper published in Neurogastroenterology & Motility (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.41)OA: bronzeTopics (44)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Jeffrey P. Staab ORCID,Eric T. Matey ORCID,Jessica Wright ORCID,Brototo Deb ORCID,Konstantinos N. Lazaridis ORCID

Live enrichment

PubMed:38072827 PMC:PMC12523929 OpenAlex:https://openalex.org/W4389569639

NIDDK NIH HHS

Grant: R01 DK078924

NIH HHS

National Institutes of Health

NIH HHS

FWCI

0.41

Citation Percentile

0.6%

Citation Trend

2024

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/nmo.14722

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/nmo.14722

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/nmo.14722

journalhttp://dx.doi.org/10.1111/nmo.14722

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38072827

Fields of Study

Gastrointestinal motility and disordersPharmacogenetics and Drug MetabolismGastroesophageal reflux and treatmentsHumansSerotonin Plasma Membrane Transport ProteinsSelective Serotonin Reuptake InhibitorsCytochrome P-450 CYP2C19Cytochrome P-450 CYP2D6BrainIrritable Bowel SyndromeGastrointestinal Diseases

MeSH Terms

BrainGastrointestinal DiseasesHumansSelective Serotonin Reuptake InhibitorsCytochrome P-450 CYP2D6Irritable Bowel SyndromeSerotonin Plasma Membrane Transport ProteinsCytochrome P-450 CYP2C19

Keywords

Serotonin transporterPharmacogenomicsCYP2D6MedicineIrritable bowel syndromeInternal medicineCYP2C19Reuptake inhibitorSerotonin reuptake inhibitorPharmacotherapyPharmacogeneticsDrug interactionGenotypeReuptakeDrugSerotoninPharmacologyBiologyGeneGeneticsGenomicsFunctional dyspepsiaOutcomes ResearchFunctional Gi DiseasesDisorder Of Gut Brain Interactions

Sustainable Development Goals

SDG 0: Good health and well-being